<bill session="104" type="h" number="2932" updated="2013-07-14T18:48:06-04:00">
  <state datetime="1996-02-01">REFERRED</state>
  <status>
    <introduced datetime="1996-02-01"/>
  </status>
  <introduced datetime="1996-02-01"/>
  <titles>
    <title as="introduced" type="official">To amend the Federal Food, Drug, and Cosmetic Act to revise the requirements of that Act relating to the dissemination of scientific information on drugs.</title>
  </titles>
  <sponsor id="400054"/>
  <cosponsors>
    <cosponsor id="400570" joined="1996-02-01"/>
    <cosponsor id="401774" joined="1996-02-01"/>
    <cosponsor id="400532" joined="1996-04-30"/>
    <cosponsor id="400576" joined="1996-02-01"/>
    <cosponsor id="400517" joined="1996-03-13"/>
    <cosponsor id="405317" joined="1996-02-01"/>
    <cosponsor id="300068" joined="1996-02-01"/>
    <cosponsor id="406625" joined="1996-05-29"/>
    <cosponsor id="400389" joined="1996-02-01"/>
    <cosponsor id="400398" joined="1996-04-30"/>
    <cosponsor id="400404" joined="1996-04-30"/>
    <cosponsor id="400414" joined="1996-02-01"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1996-02-01">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="1996-02-09">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Drugs"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Communication in science"/>
    <term name="Deceptive advertising"/>
    <term name="Drug advertising"/>
    <term name="Drug industry"/>
    <term name="Drug utilization"/>
    <term name="Education"/>
    <term name="Educational policy"/>
    <term name="Government operations and politics"/>
    <term name="Health"/>
    <term name="Health insurance"/>
    <term name="Insurance companies"/>
    <term name="Journalism"/>
    <term name="Labeling"/>
    <term name="Packaging"/>
    <term name="Periodicals"/>
    <term name="Pharmaceutical research"/>
    <term name="Science, technology, communications"/>
    <term name="Textbooks"/>
  </subjects>
  <amendments/>
  <summary>2/1/1996--Introduced.
Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved new drug application to distribute in any manner to a health professional (including insurers) a reprint of an article in an independent peer-reviewed medical textbook, journal, or medical compendium if the reprint is accompanied by a copy of the package insert and a statement that the reprint has not been approved by the Food and Drug Administration. Declares that the reprints shall not be regulated as advertising or labeling. Prohibits the Secretary of Health and Human Services from preventing advertising or labeling regarding an approved indication for a new drug, and for any pharmacoeconomic information relating to a drug, unless the Secretary determines in writing that the advertising or labeling is likely to cause unsafe or ineffective misuse.</summary>
</bill>
